STERIS plc STE
208.93
0.16
0.08%
as of 25 Sep
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
STERIS plc (STE) Revenue growth
STERIS plc's revenue growth over the twelve months to 30 June 2026 was 8.37%, down 0.4 percentage points from fiscal 2026 (8.73%). Over the past ten years it has ranged from 0.28% (fiscal 2018) to 35.9% (fiscal 2022); the current reading is higher than 50% of that period. That is in line with the Medical Devices industry median of 8.80% and in line with the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2026 | 8.73% | 2.49 |
| FY2025 | 6.24% | (7.04) |
| FY2024 | 13.3% | 5.87 |
| FY2023 | 7.41% | (28.50) |
| FY2022 | 35.9% | 33.38 |
| FY2021 | 2.53% | (6.41) |
| FY2020 | 8.94% | 2.75 |
| FY2019 | 6.19% | 5.91 |
| FY2018 | 0.28% | (16.43) |
| FY2017 | 16.7% | (4.29) |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 7.30% | 0.02 |
| Mar 2026 | 7.28% | (1.88) |
| Dec 2025 | 9.16% | (0.73) |
| Sep 2025 | 9.89% | 1.17 |
| 42 more quarters | Free account |
Against its own ten years
Low 0.28%
High 35.9%
Ten-year median
8.84%
Current reading's percentile
50
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PEN Penumbra, Inc. compare | 17.6% |
| DXCM DexCom, Inc. compare | 15.5% |
| PHG Koninklijke Philips N.V. compare | 9.11% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 8.62% |
| STE STERIS plc | 8.37% |
| GEHC GE HealthCare Technologies Inc. compare | 6.51% |
| SNN Smith & Nephew SNATS, Inc. compare | 4.81% |
| BIO Bio-Rad Laboratories, Inc. compare | 1.37% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 1.37% |
| Medical Devices industry median | 8.80% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement